 Thus, dehydrons constitute effective selectivity filters for drug design, giving rise to so-called "wrapping technology", a platform to design safer drugs.This technology was first applied by Fernandez and collaborators to redesign the anticancer drug Gleevec, in order to remove its potential cardiotoxicity.Fernandez has published books and peer-reviewed articles.